Search results
Current Drug Targets aims to cover developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. receptors, enzymes, genes.
Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes.
Current Cancer Drug Targets publishes original research articles, letters/commentary/perspectives, reviews / mini-reviews, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cancer.
Read the latest articles of Current Cancer Drug Targets at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature.
Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will be devoted to a single timely topic, with series of in-depth reviews, written by leaders in the field, covering a range of current topics on drug targets. These issues will be organized and led by a guest editor who is a recognized expert in the overall ...
Feb 20, 2024 · NMPA and FDA-approved targeted drugs by modality, 2023. a Small molecules and protein-based drugs comprised a significant majority of NMPA approvals, while oligonucleotides only represented a...
Apr 2, 2024 · Novel drug targets in 2023. By. Sorin Avram, Liliana Halip, Ramona Curpan & Tudor I. Oprea. In 2023, 49 novel drugs (excluding vaccines and gene therapies) were approved for the first time in the...
These biomolecules include 667 human-genome-derived proteins targeted by drugs for human disease. Analysis of these drug targets indicates the continued dominance of privileged target families across disease areas, but also the growth of novel first-in-class mechanisms, particularly in oncology.
Jul 17, 2021 · Main molecular pathways involved in heart failure (HF) pathophysiology, therapeutic targets, second messengers, adaptive, and maladaptive effects on the cardiovascular system and related drugs. Entries in italics represent the current guidelines-based drugs for heart failure.
Jul 17, 2021 · Current guideline recommended drugs classes are represented in bold red; drug classes with existing evidence on an outcome benefit in heart failure are represented in bold blue; novel possible targets are represented in green.
